Manejo de la psoriasis con luz ultravioleta A más psoraleno (PUVA) y luz ultravioleta B (UVB)

  • Juliana Calle
  • Ana María Rivas
  • María Carolina Ruiz
  • María Cristina Trujillo
  • Sol Beatriz Jiménez
  • Ángela Zuluaga
Palabras clave: fototerapia, PUVA, terapia, psoriasis phototherapy, PUVA, psoriasis

Resumen

Los grandes avances en el conocimiento de la inmunopatogénesis de la psoriasis en los últimos 10 años han llevado a la introducción de la terapia biológica. Sin embargo, la fototerapia sigue siendo un excelente recurso terapéutico para la enfermedad moderada a grave, no sólo por los bajos costos y relativa seguridad, sino por su gran efectividad, y siempre debe ser tenida en cuenta antes de someter al paciente a tratamientos con agentes biológicos. Infortunadamente, cada vez se realizan menos trabajos de investigación en fototerapia y, por lo tanto, se publican pocos artículos en la literatura médica sobre este tema.
Siendo el Centro Dermatológico CES, Sabaneta, un centro de referencia en fototerapia desde 1995, quisimos combinar la revisión de la literatura con la experiencia acumulada durante estos años para publicar una actualización y recomendaciones para el uso de la fototerapia en psoriasis.

Biografía del autor/a

Juliana Calle

Universidad CES, Medellín, Colombia.

Ana María Rivas

Universidad Pontificia Bolivariana, Medellín, Colombia

María Carolina Ruiz

Universidad CES, Medellín, Colombia.

María Cristina Trujillo

Universidad Pontificia Bolivariana, Medellín, Colombia

Sol Beatriz Jiménez

Universidad CES, Medellín, Colombia.

Ángela Zuluaga

Universidad CES, Medellín, Colombia.

Referencias bibliográficas

1. British Association of Dermatologists. BAD guidance document for the general management of psoriasis. Clinical Guidelines British Academy of Dermatology. British Association of Dermatologists. C2008. Fecha de consulta: 18 de septiembre de 2007) Disponible en: http://www.bad.org.uk/site/774/default.aspx
2. Lebwohl M. A clinician’s paradigm in the treatment of psoriasis. J Am Acad Dermatol. 2005;53:S59-69.
3. Naldi L, Rzany B. Psoriasis (chronic plaque). BMJ Clin Evid. 2007;04:1706.
4. Koo J, Lebwohl M. Duration of remission of psoriasis therapies. J Am Acad Dermatol. 1999;41:51.
5. Stern RS, Psoralen and ultraviolet a light therapy for psoriasis. N Engl J Med. 2007;357:682-90.
6. Warwick M. Psoralen ultraviolet A therapy in 2004. Photodermatol Photoimmunol Photomed. 2004;20:315-20.
7. Naldi L, Grifiths CE. Griffiths’ traditional therapies in the management of chronic plaque psoriasis. Br J Dermatol. 2005;152:597-615.
8. Aaronson DS, Lebwohl M. Review of therapy of psoriasis: the prebiologic armamentarium. Dermatol Clin. 2004;22:379-88.
9. Hôningsman H. Phototherapy for psoriasis. Clin Exp Dermatol. 2001;26:343-53.
10. Zanolli M. Phototherapy arsenal in the treatment of psoriasis. Dermatol Clin. 2004;22:397-406.
11. A. Nast Æ I. Kopp Æ M. Augustin. German evidence-based guidelines for the treatment of psoriasis vulgaris. Arch Dermatol Res. 2007;299:111-38.
12. Hôningsman H. Phototherapy for psoriasis. Clin Exp Dermatol. 2001;26:343-53.
13. Tpozo-Román; A Gonzales, Velasco-Vaquero ME, NuñezCabezon M. Psoralen cream plus ultraviolet A photochemotherapy (PUVA cream). JEADV. 2006;20:136-142.
14. Gonzales-López A. Psoralen cream plus PUVA in psoriasis. Eur Acad Dermatol. 2005;20:136-42.
15. Nuñez-Cabezon M. Efectividad, PUVA gel Vs. PUVA baños,. Arch Dermatol. 2005;153-63.
16. Torras H, Aliaga A, López- Estebaranz JM. A combination therapy of calcipotriol cream and PUVA reduces the UVA dose and improves the response of psoriasis vulgaris. J Dermatol Treat. 2004;15:98-103.
17. Tzaneva S. A comparison of psoralen plus ultraviolet A (PUVA) monotherapy, tacalcitol plus PUVA and tazarotene plus PUVA in patients with chronic plaque-type psoriasis. Br J Dermatol. 2002;147:748-53.
18. Tanew A, Guggenbichler A, Hönigsmann H, Geiger JM, Fritsch P. Photochemotherapy for severe psoriasis without or in combination with acitretin: a randomized, double-blind comparison study. J Am Acad Dermatol. 1991;25:682-4.
19. Aaronson DS, Lebwohl M. Review of therapy of psoriasis: the prebiologic armamentarium. Dermatol Clin. 2004;22:379-88.
20. Ibbotson SH, Bilsland D, Cox NH, Dawe RS, Diffey B, Edwards C, et al. British Association of Dermatologists. An update and guidance on narrowband ultraviolet B phototherapy: a British Photodermatology Group Workshop Report. Br J Dermatol. 2004;151:283-97.
21. Pasker-de-Jong PC, Wielink G, van der Valk PG, van der Wilt GJ. Treatment with UV-B for psoriasis and nonmelanoma skin cancer: A systematic review of the literature. Arch Dermatol. 1999;135:834-40.
22. Tanew A, Radakovic-Fijan S, Schemper M, Hönigsmann H. Narrow band UV-B phototherapy Vs. photochemotherapy in the treatment of chronic plaque-type psoriasis: a paired comparison study. Arch Dermatol. 1999;135:519-24.
23. Gordon PM, Diffey BL, Matthews JN, Farr PM. A randomized comparison of narrow-band TL-01 phototherapy and PUVA photochemotherapy for psoriasis. J Am Acad Dermatol. 1999;41:728-32.
24. Yones SS, Palmer RA, Garibaldinos TT, Hawk JL. Randomized double-blind trial of the treatment of chronic plaque psoriasis: efficacy of psoralen-UV-A therapy Vs. narrowband UV-B therapy. Arch Dermatol. 2006;142:836-42.
25. Cameron H, Dawe RS, Yule S, Murphy J, Ibbotson SH, Ferguson J. A randomized, observer-blinded trial of twice Vs. three times weekly narrowband ultraviolet B phototherapy for chronic plaque psoriasis. Br J Dermatol. 2002;147:973-8.
26. Stern RS, Members of the Photochemotherapy Follow up Study. Genital tumors among men with psoriasis exposed to psoralens and ultraviolet A radiation (PUVA) and ultraviolet B radiation: the Photochemotherapy Follow-up Study. N Engl J Med. 1990;322:1093-7.
27. Penven K, Leroy D, Verneuil L, Faguer K, Dompmartin A. Evaluation of vaseline oil applied prior to UVB TL01 phototherapy in the treatment of psoriasis. Photodermatol Photoimmunol Photomed. 2005;21:138-41.
28. Altiner DD, Ilknur T, Fetil E, Gunes AT, Ozkan S. Comparison of weekly and daily incremental protocols of narrowband ultraviolet B phototherapy for psoriasis. J Eur Acad Dermatol Venereol. 2006;20:1076-80.
29. Boztepe G, Akinci H, Sahin S, Karaduman A, Evans SE, Erkin G, et al. In search of an optimum dose escalation for narrowband UVB phototherapy: is it time to quit 20% increments? J Am Acad Dermatol. 2006;55:269-71.
30. Walters IB, Burack LH, Coven TR, Gilleaudeau P, Krueger JG. Suberythemogenic narrowband UVB is more effective than conventional UVB in treatment of psoriasis vulgaris. J Am Acad Dermatol. 1999;40:893-900.
31. Stern RS, Armstrong RB, Anderson TF, Bickers DR, Lowe NJ, Harber L, et al. Effect of continued ultraviolet B phototherapy on the duration of remission of psoriasis: a randomized study. J Am Acad Dermatol. 1986;15:546-52.
32. Boztepe G, Karaduman A, Sahin S, Hayran M, Kolemen F. The effect of maintenance narrow-band ultraviolet B therapy on the duration of remission for psoriasis: a prospective randomized clinical trial. Int J Dermatol. 2006;45:245-50.
33. Ruzicka T, Sommerburg C, Braun-Falco O, Koster W, Lengen W, Lensing W, et al. Efficiency of acitretin in combination with UVB in the treatment of severe psoriasis. Arch Dermatol. 1990;126:482-6.
34. Lebwohl M. Acitretin in combination with UVB or PUVA. J Am Acad Dermatol. 1999;41:S22-4.
35. Kist JM, van Voorhees AS. Narrowband ultraviolet B therapy for psoriasis and other skin disorders. Adv Dermatol. 2005;21:235-50.
36. Lebwohl M, Menter A, Koo J, Feldman SR. Combination therapy to treat moderate to severe psoriasis. J Am Acad Dermatol. 2004;50:416-30.
37. Ashcroft DM, Li Wan Po A, Williams HC, Griffiths CE. Combination regimens of topical calcipotriene in chronic plaque psoriasis: systematic review of efficacy and tolerability. Arch Dermatol. 2000;136:1536-43.
38. Molin L. Topical calcipotriol combined with phototherapy for psoriasis. The results of two randomized trials and a review of the literature. Calcipotriol-UVB Study Group. Dermatology.1999;198:375-81.
39. Brands S, Brakman M, Bos JD, de Rie MA. No additional effect of calcipotriol ointment on low-dose narrow-band UVB phototherapy in psoriasis. J Am Acad Dermatol. 1999;41:991-5.
40. Lebwohl M, Hecker D, Martínez J, Sapadin A, Patel B. Interactions between calcipotriene and ultraviolet light. J Am Acad Dermatol. 1997;37:93-5.
41. Koo JY, Lowe NJ, Lew-Kaya DA, Vasilopoulos AI, Lue JC, Sefton J, et al. Tazarotene plus UVB phototherapy in the treatment of psoriasis. J Am Acad Dermatol. 2000;43:821-8.
42. Behrens S, Grundmann-Kollmann M, Schiener R, Peter RU, Kerscher M. Combination phototherapy of psoriasis with narrowband UVB irradiation and topical tazarotene gel. J Am Acad Dermatol. 2000;42:493-5.
43. Jiménez S, Plata M, Álvarez C. Comportamiento de la enfermedad en pacientes con psoriasis y vitiligo en el centro dermatológico CES Sabaneta, antes y después de una intervención psicológica. Rev Asoc Colomb Dermatol. 2008;16:258.
44. Chalela J, González C, Castro l. Guías de manejo de psoriasis. 1ª edición. Colombia. Editorial Nomos. 2008. p. 58-66.
45. Radakovic S, Seeber A, Hönigsmann H, Tanew A. Failure of short-term psoralen and ultraviolet A light maintenance treatment to prevent early relapse in patients with chronic recurring plaque-type psoriasis. Photodermatol Photoimmunol Photomed. 2009;25:90-3.
46. Patel RV, Clark LN, Lebwohl M, Weinberg J. Treatments for psoriasis and the risk of malignancy. J Am Acad Dermatol. 2009;60:1001-17.
47. Kiszewski AE, De Villa D, Scheibel I, Ricachnevsky N. An infant with acrodermatitis continua of Hallopeau: successful treatment with thalidomide and UVB therapy. Pediatr Dermatol. 2009;26:105-6.
48. Grundmann M , Ludwig R, Zollner T, Ochsendorf F, Thaci D, Boehncke W, et al. Narrowband UVB and cream psoralen – UVA combination therapy for plaque –type psoriasis. J Am Acad Dermatol. 2004;50:734-9.
49. Thomas SE, Sullivan JO, Balac N. Plasma levels of 8-methoxypsoralen following oral or bath water treatment. Br J Dermatol. 1991;125;56-8.
50. Finlay AY. Current severe psoriasis and the rule of tens. Br J Dermatol. 2005;152:861-7.
51. 51. Zanolli MD, Feldman SR. Phototherapy treatment protocols: for psoriasis and other phototherapy responsive dermatoses. New York; Parthenon Publishing Group; 2000. p. 12-15.
52. 52. Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ. United States of America. McGraw Hill. Fitzpatrick's Dermatology in General Medicine. 7th edition. McGraw Hill; 2008 p. 810.
Cómo citar
1.
Calle J, Rivas AM, Ruiz MC, Trujillo MC, Jiménez SB, Zuluaga Ángela. Manejo de la psoriasis con luz ultravioleta A más psoraleno (PUVA) y luz ultravioleta B (UVB). rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 13 de febrero de 2019 [citado 9 de diciembre de 2022];17(3):162-71. Disponible en: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/166

Descargas

Los datos de descargas todavía no están disponibles.
Publicado
2019-02-13
Sección
Artículo de revisión